Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for disorder of peroxisomal beta oxidation has been reported in the published literature.
No clinical trials have been registered for disorder of peroxisomal beta oxidation.
231 publications have been identified in PubMed for disorder of peroxisomal beta oxidation. Research spans Basic Science / Preclinical (60%), Review / Meta-Analysis (20%), and Gene Therapy / Novel Therapeutics (7%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 139 | 60% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 5:53 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries
47 |
20% |
New treatment approaches | 16 | 7% |
Patient case studies | 14 | 6% |
Disease patterns and progression | 7 | 3% |
Clinical study results | 4 | 2% |
Other research | 2 | 1% |
Testing and diagnosis research | 2 | 1% |
Huang Q (2026). [PMID: 41807981](https://pubmed.ncbi.nlm.nih.gov/41807981/). *Hum Genomics*. [Diagnostic / Biomarker]
Zhou Y (2026). [PMID: 41671881](https://pubmed.ncbi.nlm.nih.gov/41671881/). *Phytomedicine*. [Basic Science / Preclinical]
Yang K (2026). [PMID: 41519764](https://pubmed.ncbi.nlm.nih.gov/41519764/). *Lipids Health Dis*. [Review / Meta-Analysis]
Vercaemst A (2026). [PMID: 41677620](https://pubmed.ncbi.nlm.nih.gov/41677620/). *Cells*. [Review / Meta-Analysis]
Elumalai V (2026). [PMID: 32809511](https://pubmed.ncbi.nlm.nih.gov/32809511/). *Unknown Journal*. [Review / Meta-Analysis]
Wu Z (2026). [PMID: 40537027](https://pubmed.ncbi.nlm.nih.gov/40537027/). *Neural Regen Res*. [Review / Meta-Analysis]
Rafeeq M (2026). [PMID: 41832722](https://pubmed.ncbi.nlm.nih.gov/41832722/). *Curr Neuropharmacol*. [Basic Science / Preclinical]
Chen X (2026). [PMID: 42036469](https://pubmed.ncbi.nlm.nih.gov/42036469/). *Naunyn Schmiedebergs Arch Pharmacol*. [Basic Science / Preclinical]
Weiskirchen R (2026). [PMID: 41918627](https://pubmed.ncbi.nlm.nih.gov/41918627/). *RSC Chem Biol*. [Review / Meta-Analysis]
Cheng Y (2026). [PMID: 42095223](https://pubmed.ncbi.nlm.nih.gov/42095223/). *Front Nutr*. [Review / Meta-Analysis]